Myoclonic jerks in a post-transplant patient: is tacrolimus the sole culprit?
Korzets
Ze'ev
Z
Department of Nephrology, Meir Hospital, Sapir Medical Center, Kfar-Saba, Israel. zeevko@clalit.org.il
Kovatz
Suzy
S
Bernheim
Jacques
J
Iraqi
Ahmed
A
Shenkman
Louis
L
D000328:Adult; D002443:Ceftriaxone / Q000008:administration & dosage*; D004831:Epilepsies, Myoclonic / Q000188:drug therapy / Q000209:etiology*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage; D007262:Infusions, Intravenous; D007676:Kidney Failure, Chronic / Q000150:complications / Q000175:diagnosis / Q000601:surgery*; D016030:Kidney Transplantation / Q000009:adverse effects* / Q000276:immunology; D008181:Lupus Nephritis / Q000150:complications / Q000175:diagnosis; D011183:Postoperative Complications; D018570:Risk Assessment; D016559:Tacrolimus / Q000008:administration & dosage* / Q000009:adverse effects; D014057:Tomography, X-Ray Computed; D014181:Transplantation Immunology; D016896:Treatment Outcome
D007166:Immunosuppressive Agents; D002443:Ceftriaxone; D016559:Tacrolimus